Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D V Spicer

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Advances in Contraceptive Delivery Systems : CDS|January 1, 1994
Contraception and cancer preventionG Ursin, D V Spicer, M C Pike
Selective Cancer Therapeutics|January 1, 1991
Tolerance of extended (28 day) continuous infusion of 5-fluorouracil in advanced head and neck cancerS M Grunberg, C Clay, D V Spicer
Endocrinology|April 1, 1996
Experiments on proliferation of normal human breast tissue in nude mice do not show that progesterone does not stimulate breast cellsM C Pike, G Ursin, D V Spicer
Fertility and Sterility|May 1, 1996
Progesterone concentrations--physiologic or pharmacologic?D V Spicer, G Ursin, M C Pike
Lancet (London, England)|June 8, 1991
Ovarian cancer and long-term tamoxifen in premenopausal womenD V Spicer, M C Pike, B E Henderson
American Journal of Epidemiology|April 29, 1998
Problems involved in including women with simple hysterectomy in epidemiologic studies measuring the effects of hormone replacement therapy on breast cancer riskM C Pike, R K Ross, D V Spicer
Cancer Investigation|January 1, 1995
The endocrine prevention of breast cancerD V Spicer, E A Krecker, M C Pike
Journal of the National Cancer Institute|January 2, 1991
Tamoxifen and estrogen replacement therapy as agents of disease preventionD V Spicer, M C Pike, B E Henderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 9, 2001
Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatmentI T Gram, G Ursin, D V Spicer, et al.
Epidemiologic Reviews|January 1, 1993
Estrogens, progestogens, normal breast cell proliferation, and breast cancer riskM C Pike, D V Spicer, L Dahmoush, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Advances in Contraceptive Delivery Systems : CDS|January 1, 1994
Contraception and cancer preventionG Ursin, D V Spicer, M C Pike
Selective Cancer Therapeutics|January 1, 1991
Tolerance of extended (28 day) continuous infusion of 5-fluorouracil in advanced head and neck cancerS M Grunberg, C Clay, D V Spicer
Endocrinology|April 1, 1996
Experiments on proliferation of normal human breast tissue in nude mice do not show that progesterone does not stimulate breast cellsM C Pike, G Ursin, D V Spicer
Fertility and Sterility|May 1, 1996
Progesterone concentrations--physiologic or pharmacologic?D V Spicer, G Ursin, M C Pike
Lancet (London, England)|June 8, 1991
Ovarian cancer and long-term tamoxifen in premenopausal womenD V Spicer, M C Pike, B E Henderson
American Journal of Epidemiology|April 29, 1998
Problems involved in including women with simple hysterectomy in epidemiologic studies measuring the effects of hormone replacement therapy on breast cancer riskM C Pike, R K Ross, D V Spicer
Cancer Investigation|January 1, 1995
The endocrine prevention of breast cancerD V Spicer, E A Krecker, M C Pike
Journal of the National Cancer Institute|January 2, 1991
Tamoxifen and estrogen replacement therapy as agents of disease preventionD V Spicer, M C Pike, B E Henderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 9, 2001
Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatmentI T Gram, G Ursin, D V Spicer, et al.
Epidemiologic Reviews|January 1, 1993
Estrogens, progestogens, normal breast cell proliferation, and breast cancer riskM C Pike, D V Spicer, L Dahmoush, et al.
Pageof 4